Juno Capital

Juno Capital is an early-stage venture capital firm based in Philadelphia, Pennsylvania, founded in 2020 by two local entrepreneurs. The firm aims to create long-term value for its portfolio companies by leveraging its extensive platform, network, and team. Juno Capital focuses on partnering with exceptional and disruptive entrepreneurs in the greater Philadelphia area and is industry-agnostic, with a particular preference for technology business models.

Mikal Harden

Partner

7 past transactions

The Asimov Foundation

Grant in 2024
The Asimov Foundation was created by leaders in the blockchain and AI industry to break barriers between the industries that should be symbiotic. After a raise between 20+ companies TAF has $770,000 to allocate to our first hackathon on Virtuals

Tribaja

Pre Seed Round in 2022
Tribaja is a digital talent platform that uses AI and predictive analytics to provide personalized career coaching and custom career plans. It focuses on helping professionals, especially those from underrepresented groups, transition into technology roles by leveraging transferable skills. The platform connects career changers and experienced hires with opportunities in startups and tech companies, fostering equitable workplaces and diverse talent pipelines within the startup ecosystem.

LLUNA

Venture Round in 2021
LLUNA is a B2B platform that enables companies to manage and analyze personalized employment arrangements, catering specifically to the needs of HR professionals. Its workplace analytics platform provides valuable insights into employees' working styles, preferences, skills, goals, and personal information. By offering comprehensive analytics, LLUNA assists organizations in monitoring and enhancing team performance, tracking employee engagement, and identifying areas for improvement. This approach aims to foster a more engaged, productive, and satisfied workforce, ultimately helping companies attract and retain top talent throughout various life phases.

Lula Convenience

Grant in 2021
Lula is the first all-in-one delivery platform for convenience stores. Hundreds of companies are using the proprietary platform to deliver your store’s items on Uber Eats, DoorDash, Postmates, and other marketplaces directly to customers’ doorsteps.

LifeBrand

Venture Round in 2021
LifeBrand develops brand reputation and risk management technology that helps individuals and companies manage their social media presence. The platform scans past history and monitors real-time activity to detect potentially damaging posts and keywords, flagging content that could harm a user's personal or corporate brand. It enables users to scrub, edit, or remove such posts and provides ongoing monitoring to maintain a clean social media footprint and promote responsible use of social platforms.

Stimulus

Venture Round in 2020
Stimulus is a relationship intelligence platform that helps organizations optimize vendor and supplier management and procurement decisions through data-driven insights. The platform provides visibility into supplier data, enabling teams to analyze vendors, compare suppliers, collect data, and generate custom reports with real-time analytics. By integrating data across the supply chain, Stimulus helps identify opportunities and disruptions, supports risk mitigation, and drives cost savings. The company was founded in 2016 and is based in New York.

ImmunoGenesis

Seed Round in 2020
ImmunoGenesis is a biotechnology company focused on developing innovative immune therapies aimed at treating tumors that exhibit low levels of activated T cells or possess other mechanisms of immune resistance. The company specializes in creating immuno-oncology therapeutics designed to address the challenges of immunologically cold cancers, including prostate, colorectal, and pancreatic cancer. By targeting critical mechanisms of immune resistance, ImmunoGenesis aims to facilitate effective immune responses in these difficult-to-treat cancer types, ultimately providing healthcare professionals with access to advanced therapies that enhance treatment options for patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.